Year : 2007 |
Volume: 55 |
Issue Number: 6 | Page: 437-439
SYMPOSIUM
A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin) Nagpal Manish, Nagpal Kamal, Nagpal P N
|
|
|
Number of times
this article was viewed |
8465 |
Number of times
this article has been printed from the site |
231 |
Number of times
this article was emailed to others |
18 |
Remarks given by
readers [ Read ] |
0 |
|
|